Literature DB >> 9415247

Acute generalized exanthematous pustulosis following oral nystatin therapy: a report of three cases.

A Küchler1, H Hamm, B Weidenthaler-Barth, E Kämpgen, E B Bröcker.   

Abstract

We report three cases of acute generalized exanthematous pustulosis (AGEP) following oral administration of nystatin. All cases showed similar clinical features and histopathological findings, and a delayed-type hypersensitivity to nystatin could be demonstrated in patch and prick testing. Drug eruptions to nystatin are extremely rare, and, to our knowledge. AGEP has not been reported previously.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9415247

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  3 in total

1.  Acute generalised skin rash secondary to the Nystatin Oral Suspension.

Authors:  Kamal Kant Sahu; Ajay Kumar Mishra; Amos Lal; Rahul Gandhi
Journal:  BMJ Case Rep       Date:  2019-05-27

2.  [Acute generalized exanthematous pustulosis with confirmed type IV allergy. Report of 3 cases].

Authors:  K Gensch; N Hodzic-Avdagic; M Megahed; T Ruzicka; A Kuhn
Journal:  Hautarzt       Date:  2007-03       Impact factor: 0.751

3.  A 10-year-old girl with acute generalised exanthematous pustulosis.

Authors:  Wai-Ming Chan; Yat-Wah Kwan; Chi-Wai Leung
Journal:  Eur J Pediatr       Date:  2004-08-07       Impact factor: 3.860

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.